The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
On May 21, mid-stage trial data revealed that the combination therapy between Moderna and Merck reduced the risk of cancer spreading by 59% after five years of follow-up. These strong results offer new hope in cancer treatment.